Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sucralfate for Infectious Oral Ulcers in Children
NCT03241030Phase 2Completed
- Sponsor
- University of Texas at Austin
- Start
- Sep 2017
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of sucralfate in herpangina, gingivostomatitis and HIV-associated central nervous system involvement (HAND) (2 arms), sponsored by University of Texas at Austin. Primary endpoint: Oral Intake in ml/kg at 60 minutes. Started Sep 2017; status: completed.
02
Drugs
sucralfate
03
Conditions
herpanginagingivostomatitisHIV-associated central nervous system involvement (HAND)
Beyond the preview
Go deeper on NCT03241030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03241030.